Lataa...
CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans
PURPOSE: Vascular disrupting therapy of cancer has become a promising approach not only to regress tumor growth directly but also to boost the delivery of chemotherapeutics in the tumor. An imaging approach to monitor the changes in tumor vascular permeability, therefore, has important applications...
Tallennettuna:
| Julkaisussa: | Magn Reson Med |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7029807/ https://ncbi.nlm.nih.gov/pubmed/31106918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mrm.27818 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|